Quantification of GS-441524 concentration in feline plasma using high performance liquid chromatography with fluorescence detection
暂无分享,去创建一个
[1] Lihong Liu,et al. Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat , 2021, Analytical and Bioanalytical Chemistry.
[2] Miranda F. Kamal,et al. Accelerated Stability Study of the Ester Prodrug Remdesivir; Recently FDA Approved Covid-19 Antiviral Using RP-HPLC with Fluorimetric and Diode Array Detection. , 2021, Biomedical chromatography : BMC.
[3] S. Deb,et al. ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential , 2021, Pharmaceuticals.
[4] D. Teupser,et al. Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serum , 2021, Journal of Pharmaceutical and Biomedical Analysis.
[5] D. Tegunov,et al. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir , 2021, Nature communications.
[6] Miranda F. Kamal,et al. Rapid sensitive bioscreening of remdesivir in COVID-19 medication: Selective drug determination in the presence of six co-administered therapeutics , 2021, Reviews in Analytical Chemistry.
[7] K. Rosenberg. Remdesivir in The Treatment of COVID-19. , 2021, The American journal of nursing.
[8] Jincun Zhao,et al. Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models , 2020, bioRxiv.
[9] Kirtikumar C. Badgujar,et al. Remdesivir for COVID-19: A review of pharmacology, mechanism of action, in-vitro activity and clinical use based on available case studies , 2020 .
[10] D. Annane,et al. Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient , 2020, Clinical chemistry and laboratory medicine.
[11] L. Dresser,et al. Remdesivir: Review of Pharmacology, Pre‐clinical Data, and Emerging Clinical Experience for COVID‐19 , 2020, Pharmacotherapy.
[12] Ashish Ranjan Sharma,et al. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More , 2020, Archives of Medical Research.
[13] G. di Perri,et al. Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease , 2020, The Journal of antimicrobial chemotherapy.
[14] D. Muntean,et al. With or Without Internal Standard in HPLC Bioanalysis. A Case Study. , 2019, Journal of chromatographic science.
[15] N. Pedersen,et al. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis , 2019, Journal of feline medicine and surgery.
[16] N. Pedersen,et al. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies , 2018, Veterinary Microbiology.
[17] William A. Lee,et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys , 2016, Nature.
[18] C. Vaccher,et al. Quantitative analysis of drugs in biological matrices by HPLC hyphenated to fluorescence detection. , 2015, Bioanalysis.
[19] N. Pedersen. A review of feline infectious peritonitis virus infection: 1963–2008 , 2009, Journal of Feline Medicine & Surgery.
[20] K. J. O'Reilly,et al. Feline infectious peritonitis: isolation of a coronavirus , 1979, Veterinary Record.
[21] N. J. Giarman. The Quantitative Analysis of Drugs , 1955, The Yale Journal of Biology and Medicine.
[22] R. Malik. Treatment of FIP in cats with subcutaneous remdesivir followed by oral GS-441524 tablets , 2021 .